Enter your login e-mail to the account
Search
- Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology )
- Treatment of patients with low-risk myelodysplastic syndrome
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2014, Spectrum ) - Prolonged remission of recurrently relapsing immune thrombocytopenia after treatment with eltrombopag
MUDr. Kamil Diľ, MUDr. Beáta Pacanová, MUDr. Drahomír Duchoň
(S3/2022, Case reports ) - Treatment options for patients with chronic immune thrombocytopenia
MUDr. Enikő Radi
(S3/2022, Case reports ) - Experience with the treatment of chronic immune thrombocytopenia
MUDr. Emília Flochová, PhD.
(S3/2022, Case reports ) - Clinical benefit of long-time treatment with thrombopoietin-receptor agonists in patient with unresponsive immune thrombocytopenia
MUDr. Tatiana Prigancová, PhD., MUDr. Denisa Jankovičová, PhD., MUDr. Anna Kyselová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2022, Case reports ) - GROWTH FACTORS IN ONCOLOGY (part 2)
MUDr. Adriana Kafková, prof. MUDr. Elena Tóthová, CSc.
(6/2007, Review articles ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment )